Translational Cancer Research

Papers
(The H4-Index of Translational Cancer Research is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
A prognostic nomogram based on least absolute shrinkage and selection operator Cox regression in patients with pulmonary large-cell neuroendocrine carcinoma68
LncRNA RP11-10E18.7 cooperates with lncRNA RP11-481C4.2 to affect the overall survival of breast cancer patients: a TCGA-based retrospective study60
Advanced non-small cell lung cancer treated with palliative systemic therapy complicated by calvarial metastasis: a case report42
Molecular basis of heterogeneity in small cell lung cancer33
First-line therapy for recurrent metastatic head and neck squamous cell carcinoma: every rose has its thorn32
Efficacy of second- and third-line chemotherapy after chemotherapy with platinum doublet and immunotherapy in non-small cell lung cancer: a descriptive study31
Efficacy, safety and pharmacokinetics of apatinib plus etoposide versus apatinib alone for platinum-resistant recurrent ovarian cancer: protocol of a multicenter, open-label, randomized phase 2 trial25
Genome-wide profiling of a prognostic RNA-binding protein signature in esophageal cancer24
The efficacy and safety of apatinib in patients with heavily pretreated end-stage cancer: a retrospective study23
Establishment and validation of a prognostic prediction model for glioma based on key genes and clinical factors22
Construction of molecular subtypes and prognostic model for breast cancer based on sulfur metabolism-related genes20
Identification of neuronal synapse-related signatures and potential therapeutic drugs in colorectal cancer based on machine learning algorithms and molecular docking20
Key considerations for interpreting patient-reported outcomes in deep inferior epigastric artery perforator flap reconstruction with post-mastectomy radiotherapy20
Unveiling prognostic factors and predictive modeling in lung adenocarcinoma with neuroendocrine differentiation19
Does circulating DNA tumor fraction add value to prostate-specific antigen in metastatic castration-resistant prostate cancer?19
Gastric cancer prognosis: unveiling autophagy-related signatures and immune infiltrates18
Development and validation of a prognosis model for patients with brain-metastasis non-small cell lung cancer by machine-learning18
MiR-193b as an effective biomarker in human cancer prognosis for Asian patients: a meta-analysis17
Clinicopathological characteristics and long-term prognosis of duodenal signet ring cell carcinoma: a SEER-based analysis17
OIP5-AS1/miR-455-3p/microfibril-associated protein 2 axis exacerbates the progression of thyroid carcinoma17
Adagrasib in the treatment of KRASG12C-mutated non-small cell lung cancer: a cost-effectiveness analysis17
Effects of p-cresol, a uremic toxin, on cancer cells17
0.13307023048401